John R Bergquist - JoVE Visualize

Showing results (31-40 of 44) with videos related to

Pageof 5

Sort By:

Laboratory Investigation; a Journal of Technical Methods and Pathology|March 10, 2018

Patient-derived xenograft cryopreservation and reanimation outcomes are dependent on cryoprotectant typeTommy Ivanics, John R Bergquist, Gang Liu, et al.

HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 23, 2016

Mixed hepatocellular and cholangiocarcinoma: a rare tumor with a mix of parent phenotypic characteristicsJohn R Bergquist, Ryan T Groeschl, Tommy Ivanics, et al.

Surgery|August 15, 2016

Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer DatabaseChristopher R Shubert, John R Bergquist, Ryan T Groeschl, et al.

Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 2, 2016

Outcomes of Pancreaticoduodenectomy for Pancreatic Neuroendocrine Tumors: Are Combined Procedures Justified?Cornelius A Thiels, John R Bergquist, Danuel V Laan, et al.

Journal of the American College of Surgeons|April 7, 2016

Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database StudyJohn R Bergquist, Carlos A Puig, Christopher R Shubert, et al.

Diseases of the Colon and Rectum|November 9, 2016

Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer DatabaseJohn R Bergquist, Cornelius A Thiels, Blake A Spindler, et al.

International Journal of Surgery (London, England)|March 3, 2018

Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study)John R Bergquist, Harsh N Shah, Elizabeth B Habermann, et al.

In Vivo (Athens, Greece)|August 31, 2023

Therapeutic Efficacy of Temsirolimus in a Patient-derived Model of Metastatic Fibrolamellar Hepatocellular CarcinomaJennifer L Leiting, Matthew C Hernandez, John R Bergquist, et al.

Cancer Medicine|July 21, 2021

Perception versus reality: A National Cohort Analysis of the surgery-first approach for resectable pancreatic cancerJohn R Bergquist, Cornelius A Thiels, Christopher R Shubert, et al.

BMC Surgery|July 29, 2020

Emergent pancreatectomy for neoplastic disease: outcomes analysis of 534 ACS-NSQIP patientsMichael R Driedger, Carlos A Puig, Cornelius A Thiels, et al.

Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:

Pageof 5

Laboratory Investigation; a Journal of Technical Methods and Pathology|March 10, 2018

Patient-derived xenograft cryopreservation and reanimation outcomes are dependent on cryoprotectant typeTommy Ivanics, John R Bergquist, Gang Liu, et al.

HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 23, 2016

Mixed hepatocellular and cholangiocarcinoma: a rare tumor with a mix of parent phenotypic characteristicsJohn R Bergquist, Ryan T Groeschl, Tommy Ivanics, et al.

Surgery|August 15, 2016

Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer DatabaseChristopher R Shubert, John R Bergquist, Ryan T Groeschl, et al.

Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 2, 2016

Outcomes of Pancreaticoduodenectomy for Pancreatic Neuroendocrine Tumors: Are Combined Procedures Justified?Cornelius A Thiels, John R Bergquist, Danuel V Laan, et al.

Journal of the American College of Surgeons|April 7, 2016

Carbohydrate Antigen 19-9 Elevation in Anatomically Resectable, Early Stage Pancreatic Cancer Is Independently Associated with Decreased Overall Survival and an Indication for Neoadjuvant Therapy: A National Cancer Database StudyJohn R Bergquist, Carlos A Puig, Christopher R Shubert, et al.

Diseases of the Colon and Rectum|November 9, 2016

Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer DatabaseJohn R Bergquist, Cornelius A Thiels, Blake A Spindler, et al.

International Journal of Surgery (London, England)|March 3, 2018

Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study)John R Bergquist, Harsh N Shah, Elizabeth B Habermann, et al.

In Vivo (Athens, Greece)|August 31, 2023

Therapeutic Efficacy of Temsirolimus in a Patient-derived Model of Metastatic Fibrolamellar Hepatocellular CarcinomaJennifer L Leiting, Matthew C Hernandez, John R Bergquist, et al.

Cancer Medicine|July 21, 2021

Perception versus reality: A National Cohort Analysis of the surgery-first approach for resectable pancreatic cancerJohn R Bergquist, Cornelius A Thiels, Christopher R Shubert, et al.

BMC Surgery|July 29, 2020

Emergent pancreatectomy for neoplastic disease: outcomes analysis of 534 ACS-NSQIP patientsMichael R Driedger, Carlos A Puig, Cornelius A Thiels, et al.

Pageof 5